Algo version: 0.98b
Mabwell (Shanghai) is listed at the SHH Exchange
Mabwell (Shanghai) [688062.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is Mabwell (Shanghai) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Mabwell (Shanghai) 10 years ago, but if you had invested on Tuesday 18th of January 2022 when the price was CNY24.50, you would have made a loss of CNY-1.290 per share or -5.27%

Yes, the average daily trading liquidity for Mabwell (Shanghai) is CNY2.92 million. You should therefore be able to get in and out of your positions relatively fast.

Mabwell (Shanghai) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Mabwell (Shanghai) to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.